Pierre Fabre Laboratories Bets On Generative AI With Iktos To Reimagine The Future Of Oncology Drug Discovery

Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, ann...

January 9, 2026 | Friday | News
Iktos And Servier Enter Strategic AI Led Drug Discovery Collaboration Valued At Over €1 Billion

Iktos, a leader in Artificial Intelligence (AI) and Robotics applied to drug discovery, announced a landmark multi-targe...

January 8, 2026 | Thursday | News
Singapore's Hyphens Pharma out-licences Cerapro® MED to six European countries

Singapore-based Hyphens Pharma International has granted the rights to commercialise its innovative product, Cerapro®...

January 5, 2026 | Monday | News
Volpak's Barcelona plant sets industry benchmark with smart intralogistics system

Volpak, a Coesia company and global leader in HFFS solutions for flexible packaging, has unveiled a groundbreaking ...

December 9, 2025 | Tuesday | News
Korea's Seegene establishes French subsidiary to expand European footprint

South Korea-based Seegene, Inc., a global leader in molecular diagnostics (MDx), has announced the establishment of...

December 6, 2025 | Saturday | News
Samsung Bioepis announces launch of Denosumab Biosimilars, OBODENCE™ and XBRYK™, in Europe

South Korea-based Samsung Bioepis Co. has announced the launch of OBODENCE™ (60 mg pre-filled syringe) a...

December 1, 2025 | Monday | News
Japan's Kaneka expands global reach with launch of brain aneurysm embolisation coil in Europe

Japan's Kaneka Corporation has begun sales of its i-ED COIL™, a brain aneurysm embolisation coil, in Europe as of ...

November 10, 2025 | Monday | News
Thermo Fisher Scientific announces R&D partnership with AstraZeneca BioVentureHub

The PPD™ clinical research business of Thermo Fisher Scientific, has announced a new research and development (R&a...

October 6, 2025 | Monday | News
Japan's Olympus launches AI-powered endoscopy in US & Europe markets

Japan-based medtech company Olympus Corporation has announced the commercial launch of its OLYSENSE™&nbs...

September 30, 2025 | Tuesday | News
PlasmidFactory Founder Dr. Martin Schleef Awarded NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory GmbH, Dr. Martin Schleef, was honored in Düsseldorf with the In...

September 11, 2025 | Thursday | News
Johnson & Johnson introduces new lenses in Europe and the Middle East for astigmatic patients with presbyopia

Johnson & Johnson has announced the launch of two new products to meet the evolving needs of astigmatic patients in ...

September 5, 2025 | Friday | News
Eppendorf Launches Research® 3 neo Pipettes, Redefining Accuracy, Ergonomics, and Sustainability

Eppendorf announced the worldwide sales start of its next generation of mechanical pipettes, the Eppendorf Research®...

September 2, 2025 | Tuesday | News
UK supports world-first library of vaccine-enhancing adjuvants

Scientists have launched the first-ever library of adjuvants - substances that could boost the performance of vaccines t...

August 4, 2025 | Monday | News
National University of Singapore inks heathcare MoU with Germany's Robert Koch Institute

The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Robert Koch Institute (RKI), Be...

July 29, 2025 | Tuesday | News
Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline

Sanofi has entered into an agreement to acquire Vicebio Ltd, a privately held biotechnology company headquartered in Lon...

July 23, 2025 | Wednesday | News
Swiss biotech continues to focus on international collaborations

Over the last 50 years, Switzerland has emerged as one of the most innovative and collaborative biotech hubs in the worl...

July 16, 2025 | Wednesday | Opinion
Samsung Bioepis proposes to bridge policy gaps for timely access of biosimilar medicines in Europe

South Korea-based biopharmaceutical company Samsung Bioepis has published a whitepaper titled ‘Solving the Biosimi...

July 14, 2025 | Monday | News
China's CStone inks deal worth $192.5 M with Istituto Gentili to commercialise cancer drug in Europe

China-based CStone Pharmaceuticals has announced an exclusive partnership with Istituto Gentili, a leading European biop...

July 10, 2025 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls